NCT00981175 - A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults | Biotech Hunter

Enrollment

202

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

February 29, 2008

Conditions

EncephalitisJapanese Encephalitis

Interventions

BIOLOGICAL

Live attenuated Japanese encephalitis virus, then ChimeriVax diluent

ChimeriVax™-JE, 0.5 mL subcutaneous on Day 0; ChimeriVax diluent 0.5 mL subcutaneous on Day 28

BIOLOGICAL

ChimeriVax diluent, then Live attenuated Japanese encephalitis virus

ChimeriVax diluent, 0.5 mL subcutaneous on Day 0 and ChimeriVax™-JE, 0.5 mL subcutaneous on Day 28.

Trial Locations (1)

Enoggera